• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环微小RNA-21表达作为口腔黏膜下纤维化和口腔鳞状细胞癌的新型血清生物标志物

Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.

作者信息

Singh Pooja, Srivastava Anand Narain, Sharma Rolee, Mateen Saboor, Shukla Bharat, Singh Alok, Chandel Siddhartha

机构信息

Department of Pathology, Era’s Lucknow Medical College and Hospital, Lucknow. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1053-1057. doi: 10.22034/APJCP.2018.19.4.1053.

DOI:10.22034/APJCP.2018.19.4.1053
PMID:29699056
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6031776/
Abstract

Background: Circulating miRNAs (miRs) in the biofluids such as serum and plasma act as potential biomarkers for early diagnosis, treatment and prognosis. In the present study, an attempt made to see the expression of miR-21 in serum of 20 cases of Oral sub-mucous fibrosis (OSMF), 20 cases of Oral squamous cell carcinoma and 40 healthy volunteers. The expression of miR-21 was evaluated in relation to different demographical and clinicopathological features such as sex, tobacco, pan-masala, alcohol, smoking and clinical staging respectively with an aim to identify correlation with oral pre-cancer and cancer stages. Materials and Methods: The relative expression level of miR-21 was determined by quantitative real-time RT-PCR (qRT-PCR) in the sera of 20 OSCC, 20 OSMF patients and 40 healthy subjects as a control. Association between expression of miR-21 and OSCC clinical stages and demographical parameters such as sex, pan-masala, tobacco, smoking, alcohol have also been analyzed in detail. Results: The results obtained by t-test revealed significant increase in the expression level of miR-21 in OSCC as compared to OSMF. The study also revealed the positive correlation between higher miR-21 expression and pan-masala chewers as shown by t-test. The statistical test, ANOVA has also indicated a positive correlation between up-regulation of miR-21 in the clinical stages of the OSCC. Conclusion: The results of present study indicated up-regulation of circulating miR-21 in serum of OSCC as compared to OSMF (p=0.001), this study also elucidated the positive correlation between miR-21 expression in OSCC/OSMF patients, only one demographical parameter (Pan-masala) and negative correlation for other parameters such as sex, tobacco, smoking, alcohol etc. Other findings suggested a significant increase (p=0.000) in the expression of miR-21 in clinical staging (I-IV) of oral cancer. More studies are needed to validate it as potential diagnostic and prognostic biomarker for OSMF and OSCC for better management.

摘要

背景

血清和血浆等生物流体中的循环微小RNA(miR)可作为早期诊断、治疗和预后的潜在生物标志物。在本研究中,试图观察20例口腔黏膜下纤维化(OSMF)患者、20例口腔鳞状细胞癌患者和40名健康志愿者血清中miR-21的表达情况。分别针对不同的人口统计学和临床病理特征(如性别、烟草、槟榔、酒精、吸烟和临床分期)评估miR-21的表达,旨在确定其与口腔癌前病变和癌症分期的相关性。材料与方法:通过定量实时逆转录聚合酶链反应(qRT-PCR)测定20例口腔鳞状细胞癌(OSCC)患者、20例OSMF患者和40名健康对照者血清中miR-21的相对表达水平。还详细分析了miR-21表达与OSCC临床分期以及人口统计学参数(如性别、槟榔、烟草、吸烟、酒精)之间的关联。结果:t检验结果显示,与OSMF相比,OSCC中miR-21的表达水平显著升高。该研究还通过t检验表明,较高的miR-21表达与嚼槟榔者之间存在正相关。方差分析(ANOVA)统计检验也表明,OSCC临床分期中miR-21的上调之间存在正相关。结论:本研究结果表明,与OSMF相比,OSCC患者血清中循环miR-21上调(p = 0.001),本研究还阐明了OSCC/OSMF患者中miR-21表达与仅一个人口统计学参数(槟榔)之间的正相关,以及与其他参数(如性别、烟草、吸烟、酒精等)之间的负相关。其他研究结果表明,口腔癌临床分期(I-IV期)中miR-21的表达显著增加(p = 0.000)。需要更多研究来验证其作为OSMF和OSCC潜在诊断和预后生物标志物的作用,以实现更好的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7440/6031776/12f21db32797/APJCP-19-1053-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7440/6031776/8ff1b9c7be23/APJCP-19-1053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7440/6031776/12f21db32797/APJCP-19-1053-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7440/6031776/8ff1b9c7be23/APJCP-19-1053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7440/6031776/12f21db32797/APJCP-19-1053-g002.jpg

相似文献

1
Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.循环微小RNA-21表达作为口腔黏膜下纤维化和口腔鳞状细胞癌的新型血清生物标志物
Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1053-1057. doi: 10.22034/APJCP.2018.19.4.1053.
2
Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by Analysis of Differential Gene Expression.揭示血清 miR-483-5p 的潜力:通过差异基因表达分析,作为 OLp 和 OSCC 患者的有前途的诊断和预后生物标志物。
Curr Pharm Des. 2024;30(4):310-322. doi: 10.2174/0113816128276149240108163407.
3
Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.口腔黏膜下纤维性变背景下的口腔鳞状细胞癌是一种具有独特临床病理特征的疾病,其预后较好。
J Oral Pathol Med. 2017 Jul;46(6):448-453. doi: 10.1111/jop.12553. Epub 2017 Feb 28.
4
Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.循环微小RNA作为口腔鳞状细胞癌手术患者复发的生物标志物
Oncotarget. 2017 Jan 31;8(5):8206-8214. doi: 10.18632/oncotarget.14143.
5
Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.循环外泌体 microRNAs 在白斑、口腔黏膜下纤维化和白斑与口腔黏膜下纤维化合并病变中的表达谱。
Head Neck Pathol. 2024 Mar 27;18(1):28. doi: 10.1007/s12105-024-01627-4.
6
Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus.miR-99a 在口腔鳞状细胞癌和糜烂型扁平苔藓血清中的抑癌作用及其循环的临床价值。
J Stomatol Oral Maxillofac Surg. 2024 Jun;125(3S):101806. doi: 10.1016/j.jormas.2024.101806. Epub 2024 Feb 24.
7
Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.血清 miR-99a 表达在口腔鳞状细胞癌中的诊断和预后价值。
Cancer Biomark. 2018;23(3):333-339. doi: 10.3233/CBM-181265.
8
Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.血清微小RNA-483-5p:口腔鳞状细胞癌患者一种新型的诊断和预后生物标志物。
Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.
9
MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.miR-92b 作为晚期口腔鳞状细胞癌患者 TPF 诱导化疗反应预测和预后评估的标志物。
Cell Mol Biol (Noisy-le-grand). 2020 Jun 5;66(3):24-31.
10
Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.血清miR-9表达降低与口腔鳞状细胞癌患者预后不良的相关性
Med Sci Monit. 2016 Jan 27;22:289-94. doi: 10.12659/msm.895683.

引用本文的文献

1
The Use of Diagnostic Tumor Markers in Detecting Tobacco- and Betel Quid-Induced Oral Squamous Cell Carcinoma: A Scoping Review of Empirical Evidence.诊断性肿瘤标志物在检测烟草和槟榔诱导的口腔鳞状细胞癌中的应用:实证证据的范围综述
Health Sci Rep. 2025 Apr 18;8(4):e70650. doi: 10.1002/hsr2.70650. eCollection 2025 Apr.
2
Decoding Salivary ncRNAomes as Novel Biomarkers for Oral Cancer Detection and Prognosis.解码唾液非编码RNA组作为口腔癌检测和预后的新型生物标志物
Noncoding RNA. 2025 Mar 20;11(2):28. doi: 10.3390/ncrna11020028.
3
MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer.

本文引用的文献

1
Where can colorectal cancer screening interventions have the most impact?结直肠癌筛查干预措施在哪些方面能产生最大影响?
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1151-6. doi: 10.1158/1055-9965.EPI-15-0082. Epub 2015 Jul 8.
2
Prevalence of oral cancer and pre-cancerous lesions and the association with numerous risk factors in North India: A hospital based study.印度北部口腔癌及癌前病变的患病率及其与多种危险因素的关联:一项基于医院的研究。
Natl J Maxillofac Surg. 2014 Jul-Dec;5(2):142-8. doi: 10.4103/0975-5950.154816.
3
Mouth self-examination in a population at risk of oral cancer.
微小RNA-21作为口腔癌中癌症干细胞特性的调节因子
Cells. 2025 Jan 10;14(2):91. doi: 10.3390/cells14020091.
4
Mechanisms and markers of malignant transformation of oral submucous fibrosis.口腔黏膜下纤维化恶性转化的机制与标志物
Heliyon. 2023 Dec 7;10(1):e23314. doi: 10.1016/j.heliyon.2023.e23314. eCollection 2024 Jan 15.
5
Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review.探索口腔黏膜下纤维化可能的癌前诊断生物标志物:一项叙述性综述。
Cancers (Basel). 2023 Sep 30;15(19):4812. doi: 10.3390/cancers15194812.
6
Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident.鉴定血清中的 microRNA 特征,可在临床上明显出现之前检测到复发性口腔鳞状细胞癌。
Br J Cancer. 2023 Nov;129(11):1810-1817. doi: 10.1038/s41416-023-02405-9. Epub 2023 Oct 5.
7
The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs.缺失性口腔癌基因(DOC1,又名 CDK2AP1)在口腔鳞状细胞癌中受多种 microRNA 下调。
Cell Death Dis. 2023 May 22;14(5):337. doi: 10.1038/s41419-023-05857-2.
8
Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy.循环微RNA作为口腔癌液体活检中的生物标志物
Biomedicines. 2023 Mar 21;11(3):965. doi: 10.3390/biomedicines11030965.
9
Bioinformatics analysis of miRNA and its associated genes to identify potential biomarkers of oral submucous fibrosis and oral malignancy.miRNA 及其相关基因的生物信息学分析,以鉴定口腔黏膜下纤维性变和口腔恶性肿瘤的潜在生物标志物。
Cancer Rep (Hoboken). 2023 Apr;6(4):e1787. doi: 10.1002/cnr2.1787. Epub 2023 Jan 28.
10
Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis.非编码 RNA:纤维化中纤维母细胞向肌成纤维细胞转化的主要调节因子。
Int J Mol Sci. 2023 Jan 16;24(2):1801. doi: 10.3390/ijms24021801.
口腔癌高危人群的口腔自我检查。
Aust Dent J. 2015 Mar;60(1):59-64. doi: 10.1111/adj.12274.
4
Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.粪便中 microRNA-135b 的鉴定作为结直肠癌和腺瘤的潜在非侵入性生物标志物。
Clin Cancer Res. 2014 Jun 1;20(11):2994-3002. doi: 10.1158/1078-0432.CCR-13-1750. Epub 2014 Apr 1.
5
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.全球口腔和口咽癌发病率趋势。
J Clin Oncol. 2013 Dec 20;31(36):4550-9. doi: 10.1200/JCO.2013.50.3870. Epub 2013 Nov 18.
6
Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.血清 miR-21 作为结直肠癌的诊断和预后生物标志物。
J Natl Cancer Inst. 2013 Jun 19;105(12):849-59. doi: 10.1093/jnci/djt101. Epub 2013 May 23.
7
Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.血清miR-21和miR-92a作为结直肠癌诊断和预后的生物标志物。
Tumour Biol. 2013 Aug;34(4):2175-81. doi: 10.1007/s13277-013-0753-8. Epub 2013 Apr 28.
8
MicroRNA-21 gene and cancer.miRNA-21 基因与癌症。
Med Oncol. 2013 Mar;30(1):376. doi: 10.1007/s12032-012-0376-8. Epub 2013 Jan 1.
9
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer.结直肠癌中 microRNA miR-21、miR-31、miR-92a、miR-101、miR-106a 和 miR-145 的临床相关性。
BMC Cancer. 2012 Nov 2;12:505. doi: 10.1186/1471-2407-12-505.
10
Plasma miR-21: a potential diagnostic marker of colorectal cancer.血浆 miR-21:结直肠癌的潜在诊断标志物。
Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.